SCHEMBL23925819

SCHEMBL23925819

CCc1c(-c2ccccc2)oc(=O)c(O)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.40
CYP3A4 P08684 3/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MAPK1 P28482 3/20 0.40
PKM P14618 2/20 0.40
LMNA P02545 2/20 0.40
TP53 P04637 2/20 0.40
ALOX15 P16050 2/20 0.40
ABCB1 P08183 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CALM1 P0DP23 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23925781 0.83 MEN1 (0.39) KDM4ECYP3A4MAPTALDH1A1CYP2C9
SCHEMBL25144838 0.82 ELANE (0.44) KDM4ECYP3A4MAPTALDH1A1MEN1
SCHEMBL23940763 0.81 KDM4E (0.37) KDM4ECYP3A4MAPTALDH1A1CYP2C9
SCHEMBL23925729 0.80 BCL2 (0.45) KDM4ECYP3A4MAPTCYP2C9MEN1
SCHEMBL25144976 0.78 ELANE (0.44) KDM4ECYP3A4MAPTALDH1A1CYP2C9
SCHEMBL23925826 0.75 MCL1 (0.49) KDM4ECYP3A4MAPTALDH1A1CYP2C9
SCHEMBL13545615 0.74 ABCG2 (0.41) KDM4ECYP3A4MAPTALDH1A1CYP2C9
SCHEMBL23925906 0.74 CYP3A4 (0.46) KDM4ECYP3A4MAPTALDH1A1CYP2C9
SCHEMBL25144975 0.72 CYP3A4 (0.43) KDM4ECYP3A4MAPTALDH1A1CYP2C9
SCHEMBL23940764 0.71 HPGD (0.42) KDM4ECYP3A4MAPTALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS CYP2B6, TYR, CYP2D6 KDM4E 1082/4885CYP3A4 43/4885MAPT 4814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.